Macquarie Group LTD Adaptive Biotechnologies Corp Transaction History

Macquarie Group LTD

  • $83.5 Billion
  • Q3 2025

A detailed history of Macquarie Group LTD transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Macquarie Group LTD holds 2,104,414 shares of ADPT stock, worth $29.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,104,414
Previous 660,056 218.82%
Holding current value
$29.7 Million
Previous $7.69 Million 309.44%
% of portfolio
0.04%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
BUY
$10.24 - $14.96 $14.8 Million - $21.6 Million
1,444,358 Added 218.82%
2,104,414 $31.5 Million
Q2 2025

Aug 14, 2025
BUY
$6.83 - $12.16 $4.51 Million - $8.03 Million
660,056 New
660,056 $7.69 Million
Q1 2024

May 14, 2024
SELL
$2.88 - $4.8 $6,085 - $10,142
-2,113 Reduced 1.71%
121,185 $389,000
Q4 2023

Feb 14, 2024
BUY
$3.46 - $5.33 $62,041 - $95,572
17,931 Added 17.02%
123,298 $604,000
Q3 2023

Nov 14, 2023
BUY
$5.07 - $8.44 $10,418 - $17,344
2,055 Added 1.99%
105,367 $574,000
Q2 2023

Aug 14, 2023
BUY
$6.19 - $8.78 $97,684 - $138,557
15,781 Added 18.03%
103,312 $693,000
Q1 2023

May 15, 2023
BUY
$7.8 - $10.11 $231,309 - $299,812
29,655 Added 51.24%
87,531 $772,000
Q4 2022

Feb 21, 2023
SELL
$6.26 - $9.34 $117,662 - $175,554
-18,796 Reduced 24.51%
57,876 $442,000
Q3 2022

Nov 14, 2022
SELL
$6.5 - $12.67 $8,599 - $16,762
-1,323 Reduced 1.7%
76,672 $553,000
Q2 2022

Aug 15, 2022
SELL
$6.4 - $14.73 $2,246 - $5,170
-351 Reduced 0.45%
77,995 $631,000
Q1 2022

May 16, 2022
BUY
$10.12 - $28.9 $35,885 - $102,479
3,546 Added 4.74%
78,346 $1.09 Million
Q4 2021

Feb 11, 2022
BUY
$25.17 - $36.85 $310,698 - $454,876
12,344 Added 19.76%
74,800 $2.1 Million
Q3 2021

Nov 12, 2021
BUY
$30.02 - $39.87 $221,967 - $294,798
7,394 Added 13.43%
62,456 $2.12 Million
Q2 2021

Aug 13, 2021
BUY
$32.22 - $44.59 $146,697 - $203,018
4,553 Added 9.01%
55,062 $2.25 Million
Q1 2021

May 14, 2021
BUY
$37.26 - $67.74 $404,159 - $734,775
10,847 Added 27.35%
50,509 $2.03 Million
Q4 2020

Feb 16, 2021
SELL
$45.01 - $65.47 $148,893 - $216,574
-3,308 Reduced 7.7%
39,662 $2.35 Million
Q3 2020

Nov 13, 2020
SELL
$35.79 - $48.81 $112,774 - $153,800
-3,151 Reduced 6.83%
42,970 $2.09 Million
Q2 2020

Aug 11, 2020
BUY
$24.95 - $48.38 $96,581 - $187,278
3,871 Added 9.16%
46,121 $2.23 Million
Q1 2020

May 15, 2020
BUY
$16.96 - $34.16 $198,381 - $399,569
11,697 Added 38.28%
42,250 $1.17 Million
Q4 2019

Feb 14, 2020
BUY
$24.56 - $32.8 $750,381 - $1 Million
30,553 New
30,553 $914,000

Others Institutions Holding ADPT

# of Institutions
289
Shares Held
147M
Call Options Held
23.5K
Put Options Held
33.3K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $2.01B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email